Nonetheless, the presence of IA-2(256-760) Abs in people with diabetes without other pancreatic Abs was shown to identify patients with clinical phenotypes that resemble classic T2D and with a slower progression towards insulin therapy than patients who were GAD Abs positive (13). The gene discussed is GAD1; the disease is type 2 diabetes mellitus.